Click here to get it Bengali The infection is caused by chikungunya chikungununya virus (chizak). Symptoms include fever and joint pain. These are typically two to twelve days after exposure. Other symptoms may include headaches, muscular pain, joint swing and a rash. Most people are good in weeks; However, occasionally joint pain can last for a few months. The risk of death among 1,000 is about 1 young, old, and other health problems, which are at risk of more serious diseases.
The virus spreads among humans by two types of mosquitoes: Aedes albopictus and Aedes aegypti. They mainly bite during the day. The virus can spread through many animals including birds and shrimp. The virus's RNA or antibodies are tested by blood. Dengue fever and gastric fever symptoms may be wrong. After single infection it is believed that most people become immune to it. The best way to prevent disease is to control overall mosquito and where the disease is common. It can be partially acquired by reducing mosquitoes from the mosquito and using insecticides and mosquito nets. There is no vaccine in 2016 and there is no specific treatment. Recommendations for fever and joint pain help include relaxation, fluid and medication.During La Réunion's outbreak in 2006, more than 50% of people over 45 years of age, with 60% of long-term muscular pain, reported after 30 years of inactivity after three years of long-term painful joints.At present, the reasons for this lasting symptom are not fully known. Chronic symptoms of anemimone or rheumatoid disease are not found by reporting the lasting symptoms. However, some evidence suggests that humans and animal models may be able to establish chronic infection in chikungunya hosts. Viral antigen initially discovered three months after the onset of the disease, in patients with a recurrent episode of the disease. In addition, after 18 months of initial infection, brain antigens and viral RNA brains are found jointly in a brain that is experiencing brain renal regeneration. Most animal models may offer continuous infection to chikungunya virus.VaccineNo approved vaccinations will be available by 2017. A phase-2 vaccine trial uses a live, antiviral virus, tested in 28 days and 85% after 98% of the test results in the prevention of virus after one year. However, 8% of people report chronic joint pain, and E2 glycoproteins decrease due to only two mutations. Alternative vaccines have been improved and performance of mouse models has been demonstrated. In August 2014, the National Institute of Allergy and Infectious Disease in the United States tested an experimental vaccine that uses virus-like particles (VLPS) instead of antenatal virus. At this stage, all 25 people participating in 1 test gave strong immune response. Stage 2 examines the use of 400 adults between 18 and 60 years and take place in 6 places in the Caribbean region. For the control of chikungunya, mosquito population control and cutting resistance will be required with vaccine to control the disease.TreatmentCurrently, no specific treatment of chikungunya is available. Supportive care is recommended, and symptoms of inflammation in the fever and syndrome include ororodial anti-inflammatory medications such as naproksen, non-aspirin analysis, such as paracetamol (acetaminophen) and fluid use. Aspirin is not recommended due to the risk of bleeding. Despite the anti-inflammatory response, corticosteroids are not recommended during severe exacerbation of the disease, as they may cause immunosuppression and the risk of infection.Possible Immunotherapy for Chikungunya Treatment Animal research using passive immunotherapy is effective, and clinical studies using Crime Immunotherapy are especially due to the transmission of suffering. Passive immunotherapy involves the management of anti-CIHV hypermiune human immunodeficiency virus (immunoglobulins) that exposes to high risk of infection in chikungunya. No antiviral treatment is currently available for the chikugunian virus, although the laboratory showed several medicines to be effective in vitro. Click here to get it Bengali
No comments:
Post a Comment